Paydirt
JD
Insider

James M Daly

Director

James M Daly (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in ACADIA Pharmaceuticals Inc. (ACAD). The largest single filing was $671K of ACAD (30,000 sh × $22.37, as filed), executed Nov 10 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$671K
shares × price, as filed
Last traded
Nov 10 2025
Filed Nov 12 2025

Median ADV $194.4M across their filed names

Open performance
Volume by month
$5.4M$2.7M$0Oct 2024Apr 2025Oct 2025Apr 2026Feb 2025 · sells $5.4MNov 2025 · sells $671K
Buys $0 Sells $6.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
ACAD ACADIA Pharmaceuticals Inc. ACAD · 0 buys · 1 sell 1 filing MDGL Madrigal Pharmaceuticals, Inc. MDGL · 0 buys · 1 sell 1 filing
Recent filings
ACADSALE ACADIA Pharmaceuticals Inc. View filing → $671K
30,000 sh × $22.37
Exec Nov 10 2025
Filed Nov 12 2025 · 5:30 PM ET
MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $5.4M
15,470 sh across 3 lots
Exec Feb 27 2025
Filed Feb 28 2025 · 5:30 PM ET